{
    "organizations": [],
    "uuid": "7046d063e866e138d039766b06cb7cdd048cae60",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-acadia-pharmaceuticals-says-ceo-st/brief-acadia-pharmaceuticals-says-ceo-stephen-daviss-fy-2017-total-compensation-was-15-2-mln-idUSFWN1S71AP",
    "ord_in_thread": 0,
    "title": "BRIEF-Acadia Pharmaceuticals Says CEO Stephen Davis's FY 2017 Total Compensation Was $15.2 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30 (Reuters) - ACADIA Pharmaceuticals Inc:\n* ACADIA PHARMACEUTICALS SAYS CEO STEPHEN DAVIS'S FY 2017 TOTAL COMPENSATION WAS $15.2 MILLION, INCLUDING $13.9 MILLION IN OPTION AWARDS - SEC FILING Source : bit.ly/2ra1j3J Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-01T05:52:00.000+03:00",
    "crawled": "2018-05-01T19:48:35.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "acadia",
        "pharmaceutical",
        "inc",
        "acadia",
        "pharmaceutical",
        "say",
        "ceo",
        "stephen",
        "davis",
        "fy",
        "total",
        "compensation",
        "million",
        "including",
        "million",
        "option",
        "award",
        "sec",
        "filing",
        "source",
        "company",
        "coverage"
    ]
}